Implications for employers : Employers should expect coverage of GLP-1 drugs for obesity to improve population health and employee productivity, but the return on investment from coverage is not likely to lead to lower medical costs now or in the future
Chang J, Wu T, Greenfield JR, Samocha-Bonet D, Horowitz M, Rayner CK
He completed his residency in internal medicine at Brigham and Women's Hospital in Boston.
The resulting stress may affect mitochondrial energy, antioxidant defense, neurotransmitter regulation, sleep, cognition and medication tolerance
- Take as directed by your physician or healthcare professional
An individual must inform all healthcare providers of their allergies to ensure that they do not receive any medications that may cause an adverse reaction